Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 6:19 AM ET | Feedback | Site Changes | Help
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
View Ticker Page (ENDP)
Results 1 - 10 of 28 : 123
Recs
pennysplants (99.68) Submitted: 10/01/07 4:37 PM : Start Price: $30.31 ENDP Score: -7.51
Held in there pretty well today after bad news. Me likes. A value plus growth proposition.Overall, a strong, mature company with LOTS of cash. I don't think a little bad news here and there will really hold them back. I believe the management trans...
Report this Post Replies: 1 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
antman02 (72.10) Submitted: 7/23/07 3:57 PM : Start Price: $34.22 ENDP Score: -14.48
Endo is poised to make a move up from here. Look for the brokerage houses to ride this baby to ~ $38 prior to the next earnings call. Product sales growth will be on the high side - no "pain" here !
Report this Post Replies: 0 | Reply | Permalink
StatsGeek (99.98) Submitted: 5/22/07 1:59 AM : Start Price: $34.75 ENDP Score: -15.83
This stock has two things I find attractive:1) Relatively inexpensive,2) Trading up on high volume with some call option activity suggests that could be an acquisition target. A lot of the big pharmas need to buy growth companies, and they need ...
MPOWERD (< 20) Submitted: 1/03/08 1:33 AM : Start Price: $26.59 ENDP Score: -3.37
I think this stock has excellent growth potential. Doctors are prescribing Opana and Opana ER more now that ever as an alternative to OxyContin for long term pain management.
BobinSECO (80.86) Submitted: 3/24/08 11:15 PM : Start Price: $24.79 ENDP Score: -6.88
Well, I'm big on fundamentals, especially PEG. I've owned and run small businesses, and I understand the importance of earnings and cash flow. With estimated 2008 earnings of $2.04, $2.57 for 2009, I can confidently hold this stock for a long time ...
libot02 (< 20) Submitted: 4/01/08 1:20 PM : Start Price: $24.47 ENDP Score: -2.34
ENDP 3.179,24 13% > 100% 03/31 12/31no dividend
quipo16 (29.38) Submitted: 4/30/08 12:57 PM : Start Price: $25.16 ENDP Score: -2.23
Rapinyl and Ketoprofen are in phase III and should push profits up in the next couple years.
Colli002 (< 20) Submitted: 5/06/08 5:47 PM : Start Price: $24.21 ENDP Score: 1.90
Drug MFG - Good intrinsic value to price ratio
NoTouch5Yr (57.95) Submitted: 5/22/08 4:37 PM : Start Price: $24.95 ENDP Score: -1.93
As with all my picks: A very attractive P/E, excellent EPS growth rate and high five year growth prospects.
TMFStockpick08 (< 20) Submitted: 5/27/08 10:34 AM : Start Price: $24.65 ENDP Score: -1.76
This stock was picked by TMFDasein in the 2008 TMF Stockpicking Contest.
Terms & Conditions
RSS Headlines
Fool UK